StockData
Enovis CORP logo

Enovis CORP (ENOV) stock

ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.22−0.70 (-2.51%)

Close on Nov 17, 2026Market cap $1.57BP/E –Yield –

Enovis ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Enovis's ebitda for the twelve months ending Jul 3, 2026 was $308.80M, up 80.0% year over year. For fiscal 2025 it was $219.89M, up 44.6% from the year before. Over ten years it grew -5.9% a year on average. The highest annual figure on record is $584.28M in fiscal 2014.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$219.89M+44.6%
FY2024Dec 31, 2024$152.11M+0.5%
FY2023Dec 31, 2023$151.40M+14.9%
FY2022Dec 31, 2022$131.79M+6.1%
FY2021Dec 31, 2021$124.19M+22.1%
FY2020Dec 31, 2020$101.72M-75.7%
FY2019Dec 31, 2019$419.22M+80.1%
FY2018Dec 31, 2018$232.74M+11.7%
FY2017Dec 31, 2017$208.29M-43.0%
FY2016Dec 31, 2016$365.68M-9.2%
FY2015Dec 31, 2015$402.66M-31.1%
FY2014Dec 31, 2014$584.28M+11.2%
FY2013Dec 31, 2013$525.65M+62.5%
FY2012Dec 31, 2012$323.41M+566.8%
FY2011Dec 31, 2011$48.50M-5.2%
FY2010Dec 31, 2010$51.18M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 3, 2026$88.44M+61.5%
Q1 FY2026Apr 3, 2026$79.89M+223.9%
Q4 FY2025Dec 31, 2025$624.58M+1085.4%
Q3 FY2025Oct 3, 2025-$484.11M-1325.9%
Q2 FY2025Jul 4, 2025$54.76M+154.2%
Q1 FY2025Apr 4, 2025$24.67M-35.7%
Q4 FY2024Dec 31, 2024$52.69M+3.6%
Q3 FY2024Sep 27, 2024$39.49M+12.9%
Q2 FY2024Jun 28, 2024$21.54M-74.0%
Q1 FY2024Mar 29, 2024$38.39M–
Q4 FY2023Dec 31, 2023$50.86M+594.2%
Q3 FY2023Sep 29, 2023$34.97M+8.5%
Q2 FY2023Jun 30, 2023$82.93M+45.9%
Q1 FY2023Mar 31, 2023-$17.36M-149.0%
Q4 FY2022Dec 31, 2022$7.33M–
Q3 FY2022Sep 30, 2022$32.23M-39.0%
Q2 FY2022Jul 1, 2022$56.83M+2.2%
Q1 FY2022Apr 1, 2022$35.40M-71.5%
Q4 FY2021Dec 31, 2021-$28.86M–
Q3 FY2021Oct 1, 2021$52.81M-57.1%
Q2 FY2021Jul 2, 2021$55.59M-2.1%
Q1 FY2021Apr 2, 2021$124.09M+18.0%
Q4 FY2020Dec 31, 2020-$183.24M-256.7%
Q3 FY2020Oct 2, 2020$123.01M-10.8%
Q2 FY2020Jul 3, 2020$56.78M-51.5%
Q1 FY2020Apr 3, 2020$105.17M+123.0%
Q4 FY2019Dec 31, 2019$116.91M–
Q3 FY2019Sep 27, 2019$137.97M+87.2%
Q2 FY2019Jun 28, 2019$117.17M+45.7%
Q1 FY2019Mar 29, 2019$47.17M-52.4%
Q4 FY2018Dec 31, 2018-$2.62M–
Q3 FY2018Sep 28, 2018$73.70M-31.8%
Q2 FY2018Jun 29, 2018$80.40M-24.7%
Q1 FY2018Mar 31, 2018$99.16M+7.6%
Q4 FY2017Dec 31, 2017-$98.67M-221.6%
Q3 FY2017Sep 29, 2017$108.00M+17.6%
Q2 FY2017Jun 30, 2017$106.76M–
Q1 FY2017Mar 31, 2017$92.20M–
Q4 FY2016Dec 31, 2016$81.15M–
Q3 FY2016Sep 30, 2016$91.81M–

More Enovis figures

See a number that looks wrong?